Literature DB >> 4102844

Inhibition of the anaphylactic mechanism by sympathomimetic amines.

E S Assem, H O Schild.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4102844     DOI: 10.1159/000230439

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


× No keyword cloud information.
  24 in total

1.  Enhanced effect of isoprenaline after chronic administration in microanaphylactic shock of guinea-pigs [proceedings].

Authors:  E S Assem; A D'Mello; W J Wieczorek
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

2.  Possible role of glucose-6-phosphate in the anti-anaphylactic mechanism mediated by cyclic AMP.

Authors:  T Okazaki; A Okazaki
Journal:  Experientia       Date:  1972-07-15

3.  Antagonism by beta-adrenoceptor blocking agents of the antianaphylactic effect of isoprenaline.

Authors:  E S Assem; H O Schild
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

4.  Comparison of in vivo and in vitro inhibition of the anaphylactic mechanism by beta-adrenergic stimulants and disodium cromoglycate.

Authors:  E S Assem; A W Richter
Journal:  Immunology       Date:  1971-11       Impact factor: 7.397

Review 5.  Pharmacologic modulation of inflammatory mediator release by rat mast cells.

Authors:  T J Sullivan; C W Parker
Journal:  Am J Pathol       Date:  1976-11       Impact factor: 4.307

6.  Bronchial hyperreactivity to prostaglandin F 2 and histamine in patients with asthma.

Authors:  A A Mathé; P Hedqvist; A Holmgren; N Svanborg
Journal:  Br Med J       Date:  1973-01-27

7.  Release of prostaglandins, a prostaglandin metabolite, slow-reacting substance and histamine from anaphylactic lungs, and its modification by catecholamines.

Authors:  R Liebig; W Bernauer; B A Peskar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

8.  An inhibitor of histamine release from human leukocytes.

Authors:  M T Kelly; A White
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

9.  Inhibition of allergen-induced early reactions in atopic skin by salbutamol and theophylline.

Authors:  R Grönneberg
Journal:  Agents Actions       Date:  1985-09

Review 10.  Therapeutic options in ocular allergic disease.

Authors:  M Hingorani; S Lightman
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.